Parametrica Management LTD Biogen Inc. Transaction History

Parametrica Management LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $192,433 - $250,954	-680 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $1.73 Million - $2.77 Million	-6,672 Reduced 90.75%	680 $236,000
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $882,151 - $1.03 Million	-3,631 Reduced 33.06%	7,352 $2.03 Million
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $2.2 Million - $3.31 Million	9,295 Added 550.65%	10,983 $2.69 Million
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $17,739 - $20,482	-67 Reduced 3.82%	1,688 $479,000
Q2 2020 Aug 17, 2020	BUY	$258.66 - $342.55 $453,948 - $601,175	1,755 New	1,755 $469,000
Q1 2018 Apr 24, 2018	SELL	$260.13 - $367.91 $175,067 - $247,603	-673 Closed	0 $0
Q4 2017 Feb 01, 2018	BUY	$307.64 - $344.58 $7,998 - $8,959	26 Added 4.02%	673 $214,000
Q3 2017 Oct 27, 2017	BUY	$281.15 - $329.69 $181,904 - $213,309	647	647 $203,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Parametrica Management LTD, based on Form 13F filings with the SEC.

Stay updated on Parametrica Management LTD with notifications on news.